FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288085504> ?p ?o ?g. }

• W4288085504 endingPage "2969" @default.
• W4288085504 startingPage "2954" @default.
• W4288085504 abstract "Purpose: Cancer stem cells (CSCs) are the evil source of tumor metastasis and recurrence. Polyploid giant cancer cells (PGCCs) that exhibit the characteristics of CSCs produced daughter cells via asymmetric division. The molecular mechanisms of daughter cells derived from PGCCs with high migration, invasion, and proliferation abilities in colorectal cancer (CRC) are explored in this paper based on the bioinformatics analysis. Materials and Methods: We characterized the expression of CSC-related genes in CRCs by analyzing the mRNAsi of The Cancer Genome Atlas and survival time. Weighted gene co-expression network analysis was performed to identify the modules of the hub and key genes. The migration, invasion, and proliferation abilities of cells, the expression of epithelial-mesenchymal transition (EMT)-related proteins and polo-like kinase 4 (PLK4) were compared in LoVo and Hct116 cells with and without bufalin treatment. In addition, the expression and subcellular location of cell division cycle 25C (CDC25C) in cells before and after PLK4 knockdown were assessed. Results: Eight hub genes were screened out and positively association with mRNAsi in CRCs based on bioinformatic analysis. Among them, checkpoint Kinase-1 (CHEK1), budding uninhibited by benzimidazoles 1 Homolog Beta (BUB1B) and PLK4 were closely associated with the prognosis of CRC patients. Bufalin could induce the formation of PGCCs in LoVo and Hct116 cell lines. PLK4 was overexpressed in PGCCs with progeny cells and progeny cells derived from PGCCs had strong migration and invasion abilities by expressing epithelial-mesenchymal transition (EMT)-related proteins. PLK4 could interact with CDC25C and promote CDC25C phosphorylation which was associated with the formation of PGCCs. Decreasing CDC25C expression in both LoVo and Hct116 PGCCs with progeny cells, while levels of pCDC25C-ser216 and pCDC25C-ser198 were increased in LoVo and decreased in Hct116 PGCCs with progeny cells. pCDC25C-ser216 located in the cytoplasm and pCDC25C-ser198 located in the nucleus in cells after bufalin treatment. Furthermore, expression of CDC25C, pCDC25C-ser216, and pCDC25C-ser198 was downregulated after PLK4 knockdown. Furthermore, the expression level of PLK4 was associated with differentiated degree, and lymph node metastasis in human CRC tissues. Conclusion: PLK4 contributes to the formation of PGCCs by regulating the expression of CDC25C and is associated with the expression and subcellular location of CDC25C, pCDC25C-ser216 and pCDC25C-ser198." @default.
• W4288085504 created "2022-07-28" @default.
• W4288085504 creator A5014300174 @default.
• W4288085504 creator A5016638723 @default.
• W4288085504 creator A5020034543 @default.
• W4288085504 creator A5030849116 @default.
• W4288085504 creator A5035324657 @default.
• W4288085504 creator A5056038390 @default.
• W4288085504 creator A5059410493 @default.
• W4288085504 creator A5061049387 @default.
• W4288085504 creator A5068216036 @default.
• W4288085504 date "2022-01-01" @default.
• W4288085504 modified "2023-10-05" @default.
• W4288085504 title "PLK4 is a key molecule in the formation of PGCCs and promotes invasion and migration of progeny cells derived from PGCCs" @default.
• W4288085504 cites W1492241376 @default.
• W4288085504 cites W1966327575 @default.
• W4288085504 cites W1976629222 @default.
• W4288085504 cites W1979235615 @default.
• W4288085504 cites W1981337355 @default.
• W4288085504 cites W1994545169 @default.
• W4288085504 cites W1996467959 @default.
• W4288085504 cites W2000302922 @default.
• W4288085504 cites W2014642487 @default.
• W4288085504 cites W2019075495 @default.
• W4288085504 cites W2027748580 @default.
• W4288085504 cites W2036747263 @default.
• W4288085504 cites W2042248589 @default.
• W4288085504 cites W2060631540 @default.
• W4288085504 cites W2097632835 @default.
• W4288085504 cites W2117365842 @default.
• W4288085504 cites W2535461738 @default.
• W4288085504 cites W2573970795 @default.
• W4288085504 cites W2769823260 @default.
• W4288085504 cites W2787299637 @default.
• W4288085504 cites W2787809029 @default.
• W4288085504 cites W2791737096 @default.
• W4288085504 cites W2794922249 @default.
• W4288085504 cites W2795867722 @default.
• W4288085504 cites W2803543468 @default.
• W4288085504 cites W2808423136 @default.
• W4288085504 cites W2810877455 @default.
• W4288085504 cites W2868903189 @default.
• W4288085504 cites W2885710012 @default.
• W4288085504 cites W2904516395 @default.
• W4288085504 cites W2915826945 @default.
• W4288085504 cites W2940057770 @default.
• W4288085504 cites W2941830556 @default.
• W4288085504 cites W2945568996 @default.
• W4288085504 cites W2949603126 @default.
• W4288085504 cites W2957828588 @default.
• W4288085504 cites W2971901660 @default.
• W4288085504 cites W2979787393 @default.
• W4288085504 cites W2985749341 @default.
• W4288085504 cites W3025857007 @default.
• W4288085504 cites W3033624893 @default.
• W4288085504 cites W3040614315 @default.
• W4288085504 cites W3119556397 @default.
• W4288085504 cites W3128646645 @default.
• W4288085504 cites W3204607428 @default.
• W4288085504 doi "https://doi.org/10.7150/jca.74211" @default.
• W4288085504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35912011" @default.
• W4288085504 hasPublicationYear "2022" @default.
• W4288085504 type Work @default.
• W4288085504 citedByCount "2" @default.
• W4288085504 countsByYear W42880855042023 @default.
• W4288085504 crossrefType "journal-article" @default.
• W4288085504 hasAuthorship W4288085504A5014300174 @default.
• W4288085504 hasAuthorship W4288085504A5016638723 @default.
• W4288085504 hasAuthorship W4288085504A5020034543 @default.
• W4288085504 hasAuthorship W4288085504A5030849116 @default.
• W4288085504 hasAuthorship W4288085504A5035324657 @default.
• W4288085504 hasAuthorship W4288085504A5056038390 @default.
• W4288085504 hasAuthorship W4288085504A5059410493 @default.
• W4288085504 hasAuthorship W4288085504A5061049387 @default.
• W4288085504 hasAuthorship W4288085504A5068216036 @default.
• W4288085504 hasBestOaLocation W42880855041 @default.
• W4288085504 hasConcept C104317684 @default.
• W4288085504 hasConcept C121608353 @default.
• W4288085504 hasConcept C1491633281 @default.
• W4288085504 hasConcept C173396325 @default.
• W4288085504 hasConcept C2779013556 @default.
• W4288085504 hasConcept C28328180 @default.
• W4288085504 hasConcept C29537977 @default.
• W4288085504 hasConcept C502942594 @default.
• W4288085504 hasConcept C54355233 @default.
• W4288085504 hasConcept C55427017 @default.
• W4288085504 hasConcept C76419328 @default.
• W4288085504 hasConcept C85813293 @default.
• W4288085504 hasConcept C86803240 @default.
• W4288085504 hasConcept C95444343 @default.
• W4288085504 hasConcept C96232424 @default.
• W4288085504 hasConceptScore W4288085504C104317684 @default.
• W4288085504 hasConceptScore W4288085504C121608353 @default.
• W4288085504 hasConceptScore W4288085504C1491633281 @default.
• W4288085504 hasConceptScore W4288085504C173396325 @default.
• W4288085504 hasConceptScore W4288085504C2779013556 @default.
• W4288085504 hasConceptScore W4288085504C28328180 @default.
• W4288085504 hasConceptScore W4288085504C29537977 @default.

• next